Karyopharm Therapeutics
KPTI
Insider trades and stock quote 2024-2026
All insider trades at Karyopharm Therapeutics
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/28/2026
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$7.1 |
$1,342 |
|
5/14/2026
|
Sell |
Mano, Michael |
EVP, CLO&Secretary |
$9.5 |
$2,527 |
|
5/14/2026
|
Sell |
Paulson, Richard A. |
President and CEO |
$9.5 |
$20,929 |
|
5/14/2026
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$9.5 |
$504 |
|
5/14/2026
|
Sell |
Cheng, Sohanya Roshan |
EVP & Chief Commercial Officer |
$9.5 |
$3,078 |
|
5/14/2026
|
Sell |
Rangwala, Reshma |
EVP & Chief Medical Officer |
$9.5 |
$3,876 |
|
5/14/2026
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$9.5 |
$3,829 |
|
4/21/2026
|
Sell |
Rangwala, Reshma |
EVP & Chief Medical Officer |
$8.9 |
$4,014 |
|
3/2/2026
|
Sell |
Paulson, Richard A. |
President and CEO |
$9.4 |
$116,311 |
|
3/2/2026
|
Sell |
Rangwala, Reshma |
EVP & Chief Medical Officer |
$9.4 |
$47,669 |
|
3/2/2026
|
Sell |
Mano, Michael |
EVP, CLO&Secretary |
$9.4 |
$33,178 |
|
3/2/2026
|
Sell |
Cheng, Sohanya Roshan |
EVP & Chief Commercial Officer |
$9.4 |
$43,321 |
|
3/2/2026
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$9.4 |
$47,998 |
|
3/2/2026
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$9.4 |
$5,260 |
|
2/17/2026
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$8.6 |
$3,262 |
|
2/3/2026
|
Sell |
Macomber, Lori |
EVP, CFO & Treasurer |
$6.3 |
$10,244 |
|
1/28/2026
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$7.0 |
$352 |
|
1/21/2026
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$6.0 |
$1,579 |
|
10/1/2025
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$6.3 |
$2,279 |
|
9/15/2025
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$6.4 |
$148 |
|
9/15/2025
|
Sell |
Cheng, Sohanya Roshan |
EVP & Chief Commercial Officer |
$6.4 |
$2,090 |
|
9/15/2025
|
Sell |
Rangwala, Reshma |
EVP & Chief Medical Officer |
$6.4 |
$2,623 |
|
9/15/2025
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$6.4 |
$2,578 |
|
9/15/2025
|
Sell |
Mano, Michael |
SVP, General Counsel&Secretary |
$6.4 |
$1,505 |
|
9/15/2025
|
Sell |
Paulson, Richard A. |
President and CEO |
$6.4 |
$8,083 |
|
9/3/2025
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$6.8 |
$81 |
|
7/29/2025
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$4.4 |
$835 |
|
7/22/2025
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$4.0 |
$952 |
|
5/6/2025
|
Sell |
Paulson, Richard A. |
President and CEO |
$7.1 |
$1,680 |
|
4/23/2025
|
Sell |
Rangwala, Reshma |
EVP & Chief Medical Officer |
$6.2 |
$2,585 |
|
4/4/2025
|
Sell |
Paulson, Richard A. |
President and CEO |
$3.7 |
$916 |
|
3/4/2025
|
Sell |
Mano, Michael |
SVP, General Counsel&Secretary |
$6.3 |
$17,568 |
|
3/4/2025
|
Sell |
Abate, Kristin |
Chief Accounting Officer |
$6.3 |
$3,592 |
|
3/4/2025
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$6.3 |
$22,317 |
|
3/4/2025
|
Sell |
Rangwala, Reshma |
EVP & Chief Medical Officer |
$6.3 |
$22,562 |
|
3/4/2025
|
Sell |
Paulson, Richard A. |
President and CEO |
$6.3 |
$73,555 |
|
3/4/2025
|
Sell |
Cheng, Sohanya Roshan |
EVP & Chief Commercial Officer |
$6.3 |
$21,669 |
|
2/18/2025
|
Sell |
Poulton, Stuart |
EVP, Chief Development Officer |
$0.6 |
$3,726 |
|
2/4/2025
|
Sell |
Paulson, Richard A. |
President and CEO |
$0.6 |
$2,664 |
|
1/6/2025
|
Sell |
Paulson, Richard A. |
President and CEO |
$0.8 |
$3,175 |
|
12/4/2024
|
Sell |
Paulson, Richard A. |
President and CEO |
$0.8 |
$2,932 |
|
11/5/2024
|
Sell |
Paulson, Richard A. |
President and CEO |
$0.9 |
$3,346 |
|
10/4/2024
|
Sell |
Paulson, Richard A. |
President and CEO |
$0.9 |
$3,172 |
|
9/4/2024
|
Sell |
Cheng, Sohanya Roshan |
EVP & Chief Commercial Officer |
$0.7 |
$3,866 |
|
9/4/2024
|
Sell |
Mason, Michael |
EVP, CFO & Treasurer |
$0.7 |
$5,089 |
|
9/4/2024
|
Sell |
Paulson, Richard A. |
President and CEO |
$0.7 |
$2,647 |
|
9/4/2024
|
Sell |
Mano, Michael |
SVP, General Counsel&Secretary |
$0.7 |
$2,866 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now